ARCHIVES

Niederhuber Says Resignation “Pro Forma,” Hopes To Stay As Director Or Lab Chief.

This article is from The Cancer Letter archive.

Vol. 34 No. 46 | December 19, 2008

Download PDF Visit The Full Archive

Related Articles

Five-Fold Increase in Chordoma Risk Linked to Common Gene Variant

October 26, 2012

Project Expands Group Studies To Community Oncologists.

March 10, 2000

NCI-Approved Clinical Trials

December 30, 2005

More Changes In Carcinogenesis Program At NCI: Gori, Workshops Out, Branch Chiefs Running It

November 18, 1977

Also in this 8-page issue: Richard Pazdur named director of FDA’s new Office of Oncology Drug Products.

April 22, 2005

Rogers Bill Would Authorize $937 Million For NCI In ‘78

March 4, 1977